Generic Code definition

Generic Code means the Code identified in Schedule 1.11.a(v) attached hereto, consisting of subroutines that are currently part of a Product or Derivative Work and used by DevElements or any of its Software developers in other products or for other purposes.
Sample 1Sample 2
Generic Code means the Code consisting of subroutines, if any, that are currently part of the Product and used by Broderbund, its affiliates or third parties in other products or for other purposes.
Sample 1
Generic Code means the Broad Based Black Economic Empowerment Amendment Act, 2013 1.15. Large Enterprise means an Entity with a total annual revenue of equal to or more than R50 million if it is a Contractor and or R25 million if it is a BEP. 1.16. Leviable Amount bears the definition defined in the Skills Development Levies Act of 1999 as determined using the fourth schedule of the Income Tax Act; 1.17. PPPFA means the Preferential Procurement Policy Framework Act, 2000; 1.18. PPS means the Preference Point System;
Sample 1

Examples of Generic Code in a sentence

  • This includes clinical prior authorizations, non-preferred prior authorizations, and drug utilization review edits.• The original prescription must have refills.Exception: The prescription could be new but the drug is categorized with the same Generic Code Number (GCN) class, and if the pharmacy uses the override code, the claim will pay.

  • UGC FIPS Coding and Geographic descriptors:The zone format (Z) of the Universal Generic Code (UGC) will identify each specific forecast zone within a FWF segment.

  • The VMAC methodology shall be defined as the 75th percentile cost level, or the 60th percentile cost level for unit dose drugs, of the aggregate for each generic manufacturer's drug for each Generic Code Number (GCN).

  • In terms of the Generic Code of Good Practice, an enterprise with annual total revenue of R5 million or less qualifies as an Emerging Micro Enterprise.

  • These tables include standards for individual Generic Code Numbers or Specific Therapeutic Class, minimum age, maximum age, approved standards based on relationships between a claim’s reported metric quantity and days supply, effective date and ability to immediately deny claims or override with prior authorization or allow a 30 day supply of drug to be dispensed to allow for interventions with the physician to take place.

  • Code 83 - Duplicate Paid/Captured Claim:This code is returned when a claim is submitted and the Service Product ID Number, Cardholder ID, Date of Service, and Prior Authorization Number Submitted fields match a previously paid claim and one of the following three conditions also exist:• Prescription/Service Reference Number, NDC/HCPCS (if not a compound), and Generic Code match, but the Fill Number Code is different.

  • These documents are handed off to the VISTA Generic Code Sheet module.

  • KEY MEASUREMENT PRINCIPLES4.1. Measurement principles associated with the management control element are contained in Statement 200 of Code 200 of the Amended Generic Code of Good Practice.

  • Generic Code LOO, which appears on the face of the DD Form 645 (in column 6), represents the summation (or roll-up) of the above L1_, L2_, and L4_ authorized charges for a given FMS Case.

  • The VMAC methodology shall be defined as the 75th percentile cost level, or the 60th percentile cost level for unit dose drugs, of the aggregate for each generic manufacturer’s drug for each Generic Code Number (GCN).

Related to Generic Code

  • Generic Drug means any Prescription Drug approved by the FDA that has the same bio-equivalency as a specific Brand Name Drug.

  • Generic Version means, with respect to a Licensed Product, a product (including a “biogeneric,” “follow-on biologic,” “follow-on biological medicine or product,” “follow-on protein product,” “similar biological medicine or product,” or “biosimilar product”) that: (a) within the U.S., is “biosimilar” or “interchangeable,” with respect to such Licensed Product as evaluated by the FDA or otherwise determined by Applicable Law; or (b) in the ROW, is determined by the applicable Regulatory Authority or by Applicable Law to be “similar,” “comparable,” “interchangeable,” “bioequivalent,” or “biosimilar” to such Licensed Product. For clarity, a Biosimilar of a Licensed Product shall constitute a Generic Version of such Licensed Product.

  • Generic String means a string consisting of a word or term that denominates or describes a general class of goods, services, groups, organizations or things, as opposed to distinguishing a specific brand of goods, services, groups, organizations or things from those of others.

  • Generic Product means any pharmaceutical product that (i) is sold by a Third Party that is not an Affiliate or licensee of Buyer and (ii) (a) contains the same active pharmaceutical ingredient as the Product or (b) is categorized by the applicable Governmental Entity in a country to be therapeutically equivalent to, or interchangeable with, the Product, such that the pharmaceutical product may be substituted for the Product at the point of dispensing without any intervention by the prescribing physician in such country.

  • Generic name means a short title which is descriptive of the premium and benefit patterns of a policy or a rider.

  • Generic Equivalent or "generically equivalent" means a drug that has an identical amount of the same active chemical ingredients in the same dosage form, that meets applicable standards of strength, quality and purity according to the United States pharmacopeia or other nationally recognized compendium and that, if administered in the same amounts, will provide comparable therapeutic effects. Generic equivalent or generically equivalent does not include a drug that is listed by the federal food and drug administration as having unresolved bioequivalence concerns according to the administration's most recent publication of approved drug products with therapeutic equivalence evaluations.

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Combination Product means any product that comprises a Licensed Compound or Licensed Product sold in conjunction with another active component so as to be a combination product (whether packaged together or in the same therapeutic formulation).

  • Biosimilar means a biological product that is highly similar to a specific reference biological

  • Combination Products means any product containing both a pharmaceutically active agent or ingredient which constitutes a Licensed Product and one or more other pharmaceutically active agents or ingredients which do not constitute Licensed Products.

  • Active Pharmaceutical Ingredient or “API” means the active pharmaceutical substance of the Drug in bulk form prior to incorporation into the Product.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Roll-on product means any antiperspirant or deodorant that dispenses active ingredients by rolling a wetted ball or wetted cylinder on the affected area.

  • Free product means a contaminant that is present as a non-aqueous phase liquid for chemicals whose melting point is less than 30° C (e.g., liquid not dissolved in water).

  • Generic means that no specific brand or name shall be included as part of the specifications unless such a brand or name is required to identify the intent of a purchase, order or proposal.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • regulated product means a consumer product for which a VOC standard is specified in section 94509(a), and

  • Pharmaceutical Product shall have the meaning ascribed to such term in Section 3.1(hh).

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • Therapeutic school means a residential group living facility:

  • Alternative nicotine product means any vaping product, whether or not it includes nicotine, including electronic smoking devices, that can be ingested into the body by chewing, smoking, absorbing, dissolving, inhaling, or by any other means. ‘Alternative nicotine product’ does not include:

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Brand Name Drug means a Prescription Drug that has been given a name by a manufacturer or distributor to distinguish it as produced or sold by a specific manufacturer or distributor and may be used and protected by a trademark.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Valid Claim means a claim of an issued and unexpired Patent that (i) has not been revoked or held unenforceable or invalid by a decision of a court or other Governmental Entity of competent jurisdiction from which no appeal can be taken or has been taken within the time allowed for appeal and (ii) has not been abandoned, disclaimed, denied, or admitted to be invalid or unenforceable through reissue or disclaimer or otherwise in such country.

  • Therapeutically equivalent drug products means drug products that contain the same active